⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease (IT-PD1/ NOA 26)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease (IT-PD1/ NOA 26)

Official Title: Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease (IT-PD1/ NOA 26)

Study ID: NCT05112549

Interventions

Nivolumab [Opdivo]

Study Description

Brief Summary: To determine the safety of intrathecal (IT) PD1 antibody for Intrathecal application of PD1 antibody in metastatic solid tumors with leptomeningeal disease of solid tumors.

Detailed Description: Leptmeningeal disease (LMD) is an aggressive subtype of metastatic disease in the central nervous system (CNS) and has a poor prognosis with a median overall survival of a few months.The IT-PD1 trial group wants to contribute to an improvement of this situation for LMD patients by using an intrathecal application route for the PD1 antibody, i.e. a drug that has shown clinical efficacy in the underlying tumor via the intravenous route.

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Universitätsklinikum Bonn, Bonn, , Germany

University Hospital Freiburg, Neurosurgery, Freiburg, , Germany

University Hospital Heidelberg, Neurooncology, Heidelberg, , Germany

SLK-Kliniken Heilbronn GmbH Klinik, Heilbronn, , Germany

University Hospital Mannheim, Neurology Clinic, Mannheim, , Germany

Klinikum rechts der Isar/Technische Universität München, München, , Germany

Katharinenhospital Stuttgart, Stuttgart, , Germany

University Hospital Tübingen, Neurooncology, Tübingen, , Germany

University Hospital Ulm, ECTU - Early Clinical Trail Unit, Ulm, , Germany

Contact Details

Name: Ghazaleh Tabatabai, Prof.Dr.

Affiliation: University Hospital Tuebingen

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: